As per Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are submitting Annual Report for Financial year 2024-25 including Notice of 43rd Annual ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Limited has submitted its Annual Report for FY 2024-25 along with the notice convening its 43rd Annual General Meeting (AGM) on Thursday, September 25, 2025 at 3:00 p.m. via video conferencing. The AGM business includes adoption of audited standalone and consolidated financial statements, re-appointment of a retiring director, regularization of two additional directors (Mr. Hitesh Pradeep Rijwani as Independent Director and Mr. Sarang Bharatbhai Pathak as Non-Executive Director), appointment of a new Secretarial Auditor for five years (FY 2025-26 to FY 2029-30), and a key proposal to alter the object clause of the Memorandum of Association. The board saw multiple changes during the year with several resignations and fresh appointments. Auditor Shivam Soni & Co. continues as the statutory auditor.
The most material item on the AGM agenda is the proposed alteration of the MOA's object clause, which would allow the company to branch into agro products, solar/renewable energy, infrastructure, real estate, drones, IT, data centres, and cloud services — a major diversification beyond its core biosciences identity that shareholders should evaluate carefully.